Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 9 (September)

1. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
   J Clin Oncol, 23(25): 6199-206. [Abstract] [Full-text]
2. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.
   J Clin Oncol, 23(25): 6126-31. [Abstract] [Full-text]
3. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.
   Am J Epidemiol, 162(6): 548-58. [Abstract] [Full-text]
4. Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
   Br J Cancer, 93(5): 510-4. [Abstract] [Full-text]
5. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
   Dis Colon Rectum, 48(9): 1714-22. [Abstract] [Full-text]
6. Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients.
   Dis Colon Rectum, 48(9): 1723-7. [Abstract] [Full-text]
7. Reoperation for intraluminal rectal cancer recurrence.
   Dis Colon Rectum, 48(9): 1752-4. [Abstract] [Full-text]
8. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
   Dis Colon Rectum, 48(9): 1742-51. [Abstract] [Full-text]
9. Age and colorectal cancer with focus on the elderly: trends in relative survival and initial treatment from a Danish population-based study.
   Dis Colon Rectum, 48(9): 1755-63. [Abstract] [Full-text]
10. Integrity of the anal sphincters after pouch-anal anastomosis: evaluation with three-dimensional endoanal ultrasonography.
    Dis Colon Rectum, 48(9): 1728-35. [Abstract] [Full-text]
11. Delayed treatment for rectal cancer.
    Dis Colon Rectum, 48(9): 1736-41. [Abstract] [Full-text]
12. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat.
    Dis Colon Rectum, 48(9): 1708-13. [Abstract] [Full-text]
13. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Jpn J Clin Oncol, 35(8): 453-63. [Abstract] [Full-text]
14. Randomized controlled trial to evaluate laparoscopic surgery for colorectal cancer: Japan Clinical Oncology Group Study JCOG 0404.
    Jpn J Clin Oncol, 35(8): 475-7. [Abstract] [Full-text]
15. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Am J Obstet Gynecol, 193(3): 668-74. [Abstract] [Full-text]
16. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Surgery, 138(2): 391-7. [Abstract] [Full-text]
17. Proteomic analysis of colonic myofibroblasts and effect on colon cancer cell proliferation.
    Surgery, 138(2): 382-90. [Abstract] [Full-text]
18. Colon cancer prognosis prediction by gene expression profiling.
    Oncogene, 24(40): 6155-64. [Abstract] [Full-text]
19. Macrophages direct tumour histology and clinical outcome in a colon cancer model.
    J Pathol, 207(2): 147-55. [Abstract] [Full-text]
20. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.
    J Pathol, 207(2): 164-76. [Abstract] [Full-text]
21. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.
    J Pathol, 207(2): 156-63. [Abstract] [Full-text]
22. Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: mutator, suppressor, or methylator pathway?
    Cancer Genet Cytogenet, 162(1): 68-73. [Abstract] [Full-text]
23. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death.
    Cancer Lett, 229(1): 43-8. [Abstract] [Full-text]
24. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test.
    Cancer Lett, 229(1): 33-41. [Abstract] [Full-text]
25. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
    Cancer Lett, 229(1): 25-31. [Abstract] [Full-text]
26. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.
    Cancer Lett, 229(1): 85-91. [Abstract] [Full-text]
27. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Am J Physiol Gastrointest Liver Physiol, 289(4): G696-703. [Abstract] [Full-text]
28. Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA.
    FEBS Lett, 579(23): 5123-8. [Abstract] [Full-text]
29. Cancer, aging and the optimal tissue design.
    Semin Cancer Biol, 15(6): 494-505. [Abstract] [Full-text]
30. Somatic evolution of cancer cells.
    Semin Cancer Biol, 15(6): 436-50. [Abstract] [Full-text]
31. Dynamics of colorectal cancer.
    Semin Cancer Biol, 15(6): 484-93. [Abstract] [Full-text]
32. MGMT promoter methylation and field defect in sporadic colorectal cancer.
    J Natl Cancer Inst, 97(18): 1330-8. [Abstract] [Full-text]
33. Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells.
    Int J Cancer, 117(4): 587-95. [Abstract] [Full-text]
34. A novel mouse model for segmental orthotopic colon cancer.
    Int J Cancer, 117(3): 335-9. [Abstract] [Full-text]
35. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients.
    Oncology, 69(2): 159-66. [Abstract] [Full-text]
36. Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer.
    Oncology, 69(2): 145-53. [Abstract] [Full-text]
37. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
    Oncology, 69(2): 122-9. [Abstract] [Full-text]
38. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
    Radiology, 237(1): 181-8. [Abstract] [Full-text]
39. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
    Radiology, 237(1): 123-31. [Abstract] [Full-text]
40. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells.
    Bioorg Med Chem, 13(21): 6064-9. [Abstract] [Full-text]
41. Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases.
    J Surg Oncol, 92(1): 64-9. [Abstract] [Full-text]
42. Tumor budding and evidence-based treatment of T2 rectal carcinomas.
    J Surg Oncol, 92(1): 59-63. [Abstract] [Full-text]
43. Preservation of bowel and urinary continence in the management of locally recurrent rectal cancer.
    J Surg Oncol, 92(1): 76-81. [Abstract] [Full-text]
44. Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer.
    J Surg Oncol, 92(1): 70-5. [Abstract] [Full-text]
45. Side effects during chemotherapy predict tumour response in advanced colorectal cancer.
    Br J Cancer, 93(7): 744-8. [Abstract] [Full-text]
46. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer.
    Br J Cancer, 93(7): 799-803. [Abstract] [Full-text]
47. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept.
    Am J Clin Pathol, 124(3): 380-91. [Abstract] [Full-text]
48. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
    Oncogene, 24(43): 6533-44. [Abstract] [Full-text]
49. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.
    J Clin Oncol, 23(28): 7125-34. [Abstract] [Full-text]
50. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis.
    J Med Microbiol, 54: 1031-5. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.